TransEnterix, Inc., a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it will exhibit and feature the Senhance™ Surgical Robotic System at the 46th AAGL Global Congress on Minimally Invasive Gynecologic Surgery (MIGS). The congress will be held November 12-16, 2017 in the Washington, DC area at the Gaylord National Resort and Convention Center at National Harbor.
"AAGL is the leading association promoting minimally invasive gynecologic surgery worldwide," said Mohan Nathan, Vice President of Global Marketing at TransEnterix. "The recent US market clearance of Senhance includes the field of laparoscopic gynecology. The AAGL congress is an opportunity to engage with leading gynecologists about the first surgical robotic system that brings haptic force feedback, eye-sensing camera control and responsible economics through reusable instrumentation."
TransEnterix will host a breakfast symposium for attendees titled, "Clinical Experience of the Senhance Surgical Robotic System in Gynecology" on Tuesday, November 14 at 7am ET. The keynote speaker will be Dr. Salvatore Gueli Alletti from the Agostino Gemelli University Polyclinic in Rome, Italy. Registration to attend this symposium is through the AAGL registration process.
The Senhance is available for surgeon demonstrations at the congress during exhibition hours on Tuesday, November 14 and Wednesday, November 15 from 9am to 3pm ET. Surgeons may schedule system demonstrations by signing up at the TransEnterix booth (#633). Those interested in attending the conference may register through the AAGL via https://www.aagl.org/globalcongress/.